Prime presents at: Fierce Biotech Next Gen

Event:

Fierce Biotech Next Gen – Session: “What are Cell and Gene Therapies Worth?”

Date/time:

June 30, 2022 – 9:30 a.m. Eastern

Prime participant:

Brett Sahli, Assistant Vice President, Pharmaceutical Trade Relations

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Events

September 16, 2024

Prime presents: Specialty Summit 2024

From September 16–18, 2024, the 21st annual event will connect, elevate and transform relationships, with exceptional speakers, insightful panels and in-person networking, helping to build the future of specialty

Events

April 25, 2024

Prime presents: “Beyond the Script” Episode 8

The latest episode of Prime Therapeutics/Magellan Rx's livestream series will feature critical discussions about the opioid crisis and how tools such as prior authorization can save lives

Events

April 28, 2024

Prime presents at: Asembia

Prime Therapeutics/Magellan Rx will once again join industry experts at Asembia’s 20th annual…

View all news